American Track Services acquires Universal Rail Systems and establishes North American Rail Solutions

Fort Worth, Texas, April 18, 2023 As a leading provider of inspection, maintenance, repair and specialized construction services for industrial railroad infrastructure in the United States, American Track Services (“ATS”) is proud to announce the acquisition of Universal Rail Systems (“URS”) in Canada and the creation of a new parent company, North American Rail Solutions.… Read more »

DFW Capital Partners Announces Transformative Add-On Acquisition for American Track

DFW Capital Partners (“DFW”) announced today that its portfolio company, American Track Services (“ATS”) has completed the acquisition of Universal Rail Systems (“URS”), Canada’s largest provider of railroad infrastructure inspection, maintenance, repair and construction. Headquartered in Edmonton, Alberta, and operating through 12 regional offices throughout Canada, URS is the country’s leader in preventative and emergency… Read more »

AQUALIS Acquires Northern Pipe, Inc.  

DURHAM, N.C. – AQUALIS, a portfolio company of DFW Capital Partners and the leading national provider of sustainable water management services, today announced it has acquired the assets of Northern Pipe, Inc., a wastewater and stormwater collection services and hydro-excavation company headquartered in Green Bay, Wis. Northern Pipe specializes in industrial vacuumation, televising and inspection… Read more »

AQUALIS Acquires Stormwater Solutions Engineering, LLC

DURHAM, N.C. – AQUALIS, a portfolio company of DFW Capital Partners and the nation’s leading provider of sustainable water management services, today announced it has acquired the assets of Stormwater Solutions Engineering, LLC (SSE), a leading civil engineering firm specializing in managing the treatment, storage and safe passage of stormwater, headquartered in Milwaukee. “This opportunity… Read more »

Saol Therapeutics enhances its IP portfolio

Saol Therapeutics enhances its IP portfolio for Dichloroacetate (DCA; SL-1009) in Glioblastoma and Rare Pediatric Cancers  By signing an agreement with Medosome Biotec By providing support for clinical trial treatment of GBM at the University of Florida By starting a collaborative research project in rare pediatric cancers with a leading cancer center   ROSWELL, Ga,… Read more »

Sixsense Strategy Group joins Herspiegel Consulting to Offer Expanded Launch Services To Life Sciences Clients

Yardley, PA – March 13, 2023 – Herspiegel Consulting, LLC expands its world class commercialization services with the addition of Sixsense Strategy Group (SSG). By incorporating SSG’s core strengths in Medical Strategy, KOL Engagement and Medical Communications, the company enhances its industry leading launch capabilities in the Life Sciences. Herspiegel Consulting is a full-service life… Read more »

DFW Capital Partners Named One of Top 50 Private Equity Firms for Executives

For Immediate Release February 10, 2023 Teaneck, NJ   DFW Capital Partners was named as one of the Top 50 Private Equity Firms for Executives – https://www.businesswire.com/news/home/20230208005242/en/PE-CXO-and-Falcon-Recognize-the-Top-50-Private-Equity-Firms-for-Executives The list highlights the funds whose governance style, engagement, and fit are seen as best enabling their executive partners to achieve success. The winners were selected through a… Read more »

DFW Closes Latest Investment Fund at $800 Million Hard Cap

For Immediate Release January 3, 2023 Teaneck, NJ DFW Capital Partners announced today that it has held the final closing of DFW Capital Partners VII, L.P. (“Fund VII”), an investment partnership dedicated to making control investments in lower-middle market service companies. DFW initially sought $750 million in commitments, and was over-subscribed at its hard cap… Read more »

Sebela Pharmaceuticals Announces New Division Named Sebela Women’s Health

Kelly Culwell, MD, Joins as Head of Research and Development, Women’s Health with a Focus on Innovative Products That Meet Women’s Needs ROSWELL, Ga., Nov. 15, 2022 /PRNewswire/ — Sebela Pharmaceuticals® today announced a new division of the company named Sebela Women’s Health along with the appointment of Kelly Culwell, MD, as Head of Research and Development for the… Read more »

Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights

Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada   Phase 3 Trials Initiated with Tegoprazan for the Treatment of Erosive Esophagitis and Non-erosive Reflux Disease Sebela Pharmaceuticals® has entered an exclusive partnership with HK inno.N Corporation to license tegoprazan in the United States and Canada. Under the agreement, Braintree Laboratories, a leader… Read more »